UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009130
Receipt number R000010703
Scientific Title Chlorella ingestion and suppression of resistin gene expression in borderline diabetics: a randomized, placebo-controlled study
Date of disclosure of the study information 2012/10/25
Last modified on 2014/04/28 17:35:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Chlorella ingestion and suppression of resistin gene expression in borderline diabetics:
a randomized, placebo-controlled study

Acronym

Chlorella ingestion and suppression of resistin gene expression in borderline diabetics

Scientific Title

Chlorella ingestion and suppression of resistin gene expression in borderline diabetics:
a randomized, placebo-controlled study

Scientific Title:Acronym

Chlorella ingestion and suppression of resistin gene expression in borderline diabetics

Region

Japan


Condition

Condition

borderline diabetics

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Chlorella ingestion improves blood glucose and cholesterol concentrations in mice and humans, although no reports have evaluated Chlorella effects in borderline diabetics. Therefore, we conducted a randomized, placebo-controlled trial for borderline diabetics using laboratory results and comprehensive gene analysis as outcomes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

HbA1c,HDL-C,LDL-C,TCHL,IL-6

Key secondary outcomes

Gene expression( microarray and qRT-PCR )


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Receive 8 g / day of Chlorella for 12 weeks.

Interventions/Control_2

Receive 8 g / day of Placebo(lactose) for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

55 years-old >

Gender

Male

Key inclusion criteria

1. Healthy adult Japanese males.
2. HbA1c (NGSP values) concentration; between 6.0% and 6.5% at the screening.
3. Written informed is required.

Key exclusion criteria

1. These having Food for Specified Health Uses (FOSHU) and/or health food.
2. These prescreened medicine.
3. These having a history of serious diseases in metabolic and/or endocrine system
4. Those that have extremely disheveled lifestyle and/or dietary habits.
5. Heavy alcohol drinker.
6. Those that are considered to be ineligible to participate to this test due to their abnormality at the screening test.
7. Those having an allergy to food and/or drug
8. Those participating in another trial or other investigational.
9. Those that are judged not applicable to this study by physicians.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michie Kobayashi

Organization

DNA Chip Research Inc.

Division name

Research & Development Dept.

Zip code


Address

1-1-43, Suehiro-cho, Tsurumi-ku, Yokohama

TEL

045-500-5211

Email

dnachip-support@dna-chip.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Michie Kobayashi

Organization

DNA Chip Research Inc.

Division name

Research & Development Dept.

Zip code


Address

1-1-43, Suehiro-cho, Tsurumi-ku, Yokohama

TEL

045-500-5211

Homepage URL


Email

dnachip-support@dna-chip.co.jp


Sponsor or person

Institute

CPCC Inc.

Institute

Department

Personal name



Funding Source

Organization

Sun Chlorella Corp.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

チヨダパラメディカルケアクリニック


Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 06 Month 04 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 18 Day

Last follow-up date

2010 Year 12 Month 18 Day

Date of closure to data entry

2010 Year 12 Month 27 Day

Date trial data considered complete

2011 Year 01 Month 20 Day

Date analysis concluded

2011 Year 11 Month 15 Day


Other

Other related information



Management information

Registered date

2012 Year 10 Month 17 Day

Last modified on

2014 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010703


Research Plan
Registered date File name
2014/04/17 10.06.04 糖尿病予備軍プロトコル.PDF

Research case data specifications
Registered date File name
2014/04/24 SC210C01症例報告書_仕様書.xls

Research case data
Registered date File name
2014/04/24 SC210C01症例報告書.xls